EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Fasting serum triglyceride and high-density lipoprotein cholesterol levels in patients intended to be treated for dyslipidemia

Genovefa D Kolovou, Katherine Anagnostopoulou, Nektarios D Pilatis, Klelia D Salpea, Ioannis S Hoursalas, Ilias Petropoulos, Helen I Bilianou, Dennis V Cokkinos

Vascular Health and Risk Management · 2005

DOI: 10.2147/vhrm.1.2.155.64079 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Vascular Health and Risk Management, 2005. Verfasst von Genovefa D Kolovou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Onassis Cardiac Surgery Center, Athens, Greece. genkolovou@mail.gr. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: The aim of the present investigation was to evaluate the influence of serum triglycerides (TG) on other plasma lipids in patients to be treated for dyslipidemia. METHODOLOGY: Lipid profiles of a cohort of 801 patients (487 males and 314 females) aged 57 +/- 9 years (mean +/- SD) were evaluated. Patients were stratified according to their plasma lipid levels. They were divided into various groups on the basis of serum TG (> or = 150 or or = 40 or or = 150 mg/dL had a higher total cholesterol and lower HDL-C levels compared with those with TG or = 40 mg/dL (p = 0.011 and p < 0.0001, respectively). In all patients as well as in the subgroups, an inverse correlation between TG and HDL-C was found (r = -0.377, p < 0.001). CONCLUSIONS: Although, the metabolic pathway for TG and HDL-C is closely linked, an inverse correlation between TG and HDL-C levels seems to exist in the entire sampled population. This correlation also appears to persist in fasting patients with low levels of TG.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholesterolCholesterol, HDLCohort StudiesDyslipidemiasFastingFemaleHumansHypolipidemic AgentsMaleMiddle AgedTriglycerides

Substanzen

Cholesterol, HDLHypolipidemic AgentsTriglyceridesCholesterol

Autor:innen und Institutionen

  • Cardiology Department, Onassis Cardiac Surgery Center, Athens, Greece. genkolovou@mail.gr

Zitieren

APA

Kolovou, G. D., Anagnostopoulou, K., Pilatis, N. D., Salpea, K. D., Hoursalas, I. S., Petropoulos, I., Bilianou, H. I., & Cokkinos, D. V. (2005). Fasting serum triglyceride and high-density lipoprotein cholesterol levels in patients intended to be treated for dyslipidemia. Vascular Health and Risk Management. https://doi.org/10.2147/vhrm.1.2.155.64079

Vancouver

Kolovou GD, Anagnostopoulou K, Pilatis ND, Salpea KD, Hoursalas IS, Petropoulos I, et al. Fasting serum triglyceride and high-density lipoprotein cholesterol levels in patients intended to be treated for dyslipidemia. Vascular Health and Risk Management. 2005. doi:10.2147/vhrm.1.2.155.64079

BibTeX
@article{Kolovou2005,
  author = {Kolovou, Genovefa D and Anagnostopoulou, Katherine and Pilatis, Nektarios D and Salpea, Klelia D and Hoursalas, Ioannis S and Petropoulos, Ilias and Bilianou, Helen I and Cokkinos, Dennis V},
  title = {Fasting serum triglyceride and high-density lipoprotein cholesterol levels in patients intended to be treated for dyslipidemia},
  journal = {Vascular Health and Risk Management},
  year = {2005},
  doi = {10.2147/vhrm.1.2.155.64079}
}
Kostenlos starten →